After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Axsome Therapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Axsome Therapeutics Inc is $6.12B. A total of 0.79 million shares were traded on the day, compared to an average of 953.32K shares.
Insider Activity
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, AXSM has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Pizzie Nick sold 12,000 shares of AXSM for 129.86 per share on Feb 13 ’25. After the transaction, the Chief Financial Officer now owns 42,187 company shares. In a previous transaction on Feb 14 ’25, Pizzie Nick sold 3,000 shares at 131.07 per share. AXSM shares that Chief Financial Officer owns now total 42,187.
Among the insiders who bought shares, Pizzie Nick acquired of 3,000 shares on Feb 14 ’25 at a per-share price of $131.07. In another insider transaction, Pizzie Nick bought 12,000 shares at $129.86 per share on Feb 13 ’25.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for AXSM in the last 3 months, the mean price target is $173.35 with high estimates of $212.00 and low estimates of $121.00. In terms of 52-week highs and lows, AXSM has a high of $139.13 and a low of $64.11.
As of this writing, AXSM has an earnings estimate of -$1.33 per share for the current quarter. EPS was calculated based on a consensus of 10.0 estimates, with a high estimate of -$1.06 per share and a lower estimate of -$1.63.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. AXSM’s latest balance sheet shows that the firm has $86.47M in Cash & Short Term Investments as of fiscal 2021. There were $49.71M in debt and $23.07M in liabilities at the time. Its Book Value Per Share was $1.17, while its Total Shareholder’s Equity was $15.63M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for AXSM is Buy with a score of 4.88.
